FDA Drug Topics: An Overview of FDA’s Expanded Access Program with a Focus on Individual Patient Expanded Access – February 20, 2018
FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!
On Tuesday, February 20, 2018, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: FDA Drug Topics: An Overview of FDA’s Expanded Access Program with a Focus on Individual Patient Expanded Access. This webinar discussed and summarized FDA's expanded access program, including the three types of expanded access and requirements for requesting expanded access. This webinar also reviewed the resources on expanded access available to patients and health care providers, and reviewed and explained how a physician may submit a request for individual patient expanded access using Form FDA 3926.
View Presentation (Adobe Connect): https://collaboration.fda.gov/p58xr7okhsm/
Presentation Slides: An Overview of FDA's Expanded Access Program Slides (PDF - 2.38MB)
If you have never attended an Adobe Connect meeting before:
Test your connection: Adobe Connect Diagnostic Test
Get a quick overview: Discover Adobe Connect Solutions
Adobe, the Adobe logo, Acrobat and Adobe Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.